ACHV

7.24

3.85% -0.29

Dopo l'orario di chiusura: 7.33 0.09 +1.24%

Achieve Life Sciences Inc (ACHV)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ACHV Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$7.53

Aprire:

$7.62

Volume 24 ore:

1.89M

Relative Volume:

1.25

Capitalizzazione di mercato:

$745.01M

Reddito:

Utile/perdita netta:

$-51.99M

Rapporto P/E:

-6.4904

EPS:

-1.1155

Flusso di cassa netto:

$-45.31M

1 W Prestazione:

-3.98%

1M Prestazione:

-14.62%

6M Prestazione:

+124.15%

1 anno Prestazione:

+126.96%

Intervallo 1D:

$7.05

$7.63

Intervallo di 1 settimana:

$7.05

$8.28

Portata 52W:

$2.62

$8.64

Achieve Life Sciences Inc Stock (ACHV) Company Profile

Nome

Achieve Life Sciences Inc

Settore

Healthcare (1064)

Industria

Biotechnology (595)

Telefono

425-686-1500

Indirizzo

22722 29TH DR. SE, SEATTLE, BC

Dipendente

Cinguettio

Prossima data di guadagno

2026-11-05

Ultimi documenti SEC

ACHV's Discussions on Twitter

Compare ACHV vs VRTX, MRNA, REGN, ARGX, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ACHV Achieve Life Sciences Inc	7.24	775.88M	0	-51.99M	-45.31M	-1.1155
VRTX Vertex Pharmaceuticals Inc	504.73	133.37B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	190.01	79.40B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	735.20	81.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	919.21	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	206.64	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-04-21	Iniziato	Canaccord Genuity	Buy
2025-11-25	Iniziato	Citizens JMP	Mkt Outperform
2025-08-21	Iniziato	H.C. Wainwright	Buy
2024-11-14	Iniziato	Rodman & Renshaw	Buy
2024-09-27	Iniziato	Raymond James	Strong Buy
2023-05-10	Reiterato	Maxim Group	Buy
2021-06-23	Iniziato	Oppenheimer	Outperform

Mostra tutto

Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie

Oct 01, 2026

Achieve Life Sciences appoints Benjamin Halladay as chief financial officer By Investing.com - Investing.com Canada

Oct 01, 2026

Achieve Life Sciences names Benjamin Halladay as CFO By Investing.com - Investing.com Nigeria

Oct 01, 2026

Achieve Life Sciences appoints Benjamin Halladay as CFO - TradingView

Oct 01, 2026

Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer - Yahoo Finance

Oct 01, 2026

Sep 30, 2026

Stifel initiates coverage of Achieve Life Sciences with Buy rating, $18 price target - TradingView

Sep 30, 2026

Stifel Initiates Achieve Life Sciences (ACHV) with Buy Rating on Cytisinicline Potential - GuruFocus

Sep 30, 2026

Achieve a new Buy at Stifel on potential of smoking cessation drug cytisinicline - Seeking Alpha

Sep 30, 2026

Achieve Life Sciences (NASDAQ:ACHV) Shares Gap UpStill a Buy? - MarketBeat

Sep 30, 2026

ACHV Initiates Coverage On by Stifel -- Rating Set to Buy, PT $1 - GuruFocus

Sep 30, 2026

Stifel Initiates Achieve Life Sciences at Buy With $18 Price Target - marketscreener.com

Sep 30, 2026

Sep 29, 2026

Operating cash flow per share of Achieve Life Sciences, Inc. – HAN:SP4P - TradingView

Sep 29, 2026

Stifel initiates Achieve Life Sciences stock with buy rating By Investing.com - Investing.com South Africa

Sep 29, 2026

Stifel initiates Achieve Life Sciences stock with buy rating - Investing.com

Sep 29, 2026

Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat

Sep 29, 2026

Sep 28, 2026

A yearlong quit-smoking and vaping study involved 475 adults. Results will be presented Oct. 20. - Stock Titan

Sep 28, 2026

Sep 24, 2026

Achieve Life Sciences (ACHV) Short Interest & Short Float | Updated Sep 2026 - MarketBeat

Sep 24, 2026

Sep 23, 2026

Achieve Life Sciences: Thesis Intact, Setup Remains Constructive (Rating Downgrade) (ACHV) - Seeking Alpha

Sep 23, 2026

Sep 22, 2026

Achieve Life Sciences: A Funded Manufacturing Reset, Not A Broken Clinical Thesis - Seeking Alpha

Sep 22, 2026

Sep 21, 2026

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat

Sep 21, 2026

Sep 18, 2026

Achieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200-Day Moving AverageTime to Sell? - MarketBeat

Sep 18, 2026

Sep 17, 2026